Preparation of 4- and 6-O-methyl-aclacinomycin derivatives and their antitumor activities.
D015250:Aclarubicin / Q000031:analogs & derivatives*; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000138:chemical synthesis*; D002478:Cells, Cultured; D004273:DNA, Neoplasm / Q000096:biosynthesis; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009279:Naphthacenes / Q000138:chemical synthesis / Q000494:pharmacology; D010084:Oxidation-Reduction; D012334:RNA, Neoplasm / Q000096:biosynthesis
D000903:Antibiotics, Antineoplastic; D004273:DNA, Neoplasm; D009279:Naphthacenes; D012334:RNA, Neoplasm; D015250:Aclarubicin; C031988:6-O-methylaclacinomycin; C031987:4-O-methylaclacinomycin